TEDI find consistent adulteration and risk trends across Europe's drug market since 2018, and call for more resources to improve market monitoring and harm reduction.
Michaud et al. analyse public discourse surrounding safer supply, highlighting potential implications of moral panic for people who use drugs and healthcare access.
The EU Civil Society Forum on Drugs discusses decriminalisation, focusing on members' perspectives and noting how this framework could contribute to the EU's commitment to balanced, human-rights based approach.
EuroNPUD explore community-led communicable disease testing and care integration for people who use drugs, assessing best practice and attitudes surrounding these services.
IDPC and other organisations encourage the Special Rapporteurs to acknowledge the harmful effects of criminalising drug use and sex work in relation to the policing of people living in poverty in public spaces.
Youth RISE, SSDP International and Young Wave present a sustainability framework to develop skills, knowledge, network and strategies for young people in drug-related organisations internationally.
ICON reveals challenges faced by service users, including limited treatment options and discrimination, underscoring the need for improved support and a rights-based approach.
The BOOST project seeks to combat HIV/AIDS and viral hepatitis in Europe through community-led harm reduction initiatives, aiming to enhance health services for people who use drugs and marginalised populations.
Thomson et al. examine coca, opium poppy and cannabis cultivation through the lens of agrarian political economy, drawing attention to key challenges for cultivators posed by synthetics and policy.
